Calendario›CGC›A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality
A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality
Ensayo de Canopy Growth Corp en Voluntarios sanos.
- Fase
- Fase 1/2
- Estado
- Completado
- Participantes
- 301
- Centros
- 1
- Fin del objetivo primario
- dic 2022
previstos
fecha real
Qué significa cada fase y cada estado.
Estudio de intervención, aleatorizado, triple ciego. Comenzó en may 2022.
Qué mide
Median sleep quality rating during the IP administration phase (measured with the Consensus Sleep Diary - Core Version completed within 1 hour of awakening each morning). (Days 1-7) (del registro, en inglés)
Cómo lo describe el promotor
En el documentoEn inglés, del registroThis is a randomized, double-blind, placebo-controlled, study to assess the safety and effects of CHI-560, CHI-563, CHI-564, \& CHI-565 versus placebo on sleep quality in healthy adult participants ages 18-55 years.
Más ensayos de CGC
| Ensayo | Fase | Estado | Lectura de resultados |
|---|---|---|---|
| Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic Pain | no aplica | Sin noticias del promotor | jul 2023 (prevista, ya pasada: sin actualizar en el registro) |
| CBD | Fase 1 | Interrumpido | sep 2022 (real) |
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants | Fase 1 | Completado | may 2022 (real) |
| Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity | Fase 2 | Completado | feb 2022 (real) |
| Cannabidiol | Fase 2 | Completado | sep 2021 (real) |
| CHI-907 CBD Extract and Experiences of Test Anxiety | Fase 2 | Interrumpido | jun 2021 (real) |
Todos los de CGC, en su ficha.
Ficha completa en ClinicalTrials.gov (NCT05839964), actualizada en abr 2023.